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Background:  Therapeutic hypothermia for return of spontaneous circulation after ventricular fibrillation improves neurological outcomes of 
patients with out-of-hospital cardiac arrest. With the recent introduction of therapeutic hypothermia, the application of sedation has become 
necessary in cardiac arrest patients. However, the most appropriate sedative agents for use during the procedure have yet to be determined, 
especially as regards administration of neuromuscular blocking agents (NMBA).
Methods:  We conducted a multicenter study at 14 institutions, to evaluate the effect of therapeutic hypothermia on out-of-hospital cardiac arrest, 
between January 2005 and December 2009. The committee entrusted each hospital with the timing of cooling, cooling methods, target temperature, 
duration, rewarming rate, managing complications, and sedation methods. Enrolled patients were divided into group M (maintained with NMBA) 
and group C (without NMBA). Any complications (i.e., infections), time to target temperature, temperature stability, and neurological outcomes were 
compared. A favorable outcome was defined as a Cerebral Performance Category (CPC) of 1-2.
Results:  In total, 435 patients were enrolled in this study. There were no significant differences between the two groups. As compared with group 
C (N=355), group M (N=80) had higher rates of temperature instability (35% vs. 10%, p<0.01), temperature over-shoot (25% vs. 4%, p<0.01), and 
complications (33% vs. 19%, p<0.05). Both groups had favorable outcomes (56% vs. 61%, NS).
Conclusions:  This study suggested that NMBA have higher risk of some complications and poor temperature control. An application of NMBA 
should be careful of therapeutic hypothermia, though there is no difference for favorable outcomes.
